Nika Pharmaceuticals, Inc. (NIKA)

Nika Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0	0	0.02	0	0
Cash & Short-Term Investments	0	0	0.02	0	0
Cash Growth	-9.31%	-89.37%	2168.06%	116.54%	-75.23%
Prepaid Expenses	0.02	0.02	-	-	-
Total Current Assets	0.02	0.02	0.02	0	0
Total Assets	0.02	0.02	0.02	0	0
Short-Term Debt	0.32	0.24	0.1	0.02	-
Other Current Liabilities	-	-	-	-	0.01
Total Current Liabilities	0.32	0.24	0.1	0.02	0.01
Other Long-Term Liabilities	-	-	-	-	0.01
Total Liabilities	0.32	0.24	0.1	0.02	0.02
Common Stock	0.1	0.1	0.09	0.09	0.04
Additional Paid-In Capital	8.6	8.6	3.23	3.23	0.09
Retained Earnings	-9	-8.93	-3.4	-3.34	-0.15
Total Common Equity	-0.3	-0.22	-0.08	-0.02	-0.02
Shareholders' Equity	-0.3	-0.22	-0.08	-0.02	-0.02
Total Liabilities & Equity	0.02	0.02	0.02	0	0
Total Debt	0.32	0.24	0.1	0.02	-
Net Cash (Debt)	-0.32	-0.24	-0.08	-0.02	0
Net Cash Growth	-	-	-	-	-75.23%
Net Cash Per Share	-0.00	-0.00	-0.00	-0.00	-
Filing Date Shares Outstanding	1,048	1,026	876.09	876.09	396.09
Total Common Shares Outstanding	1,048	1,019	876.09	876.09	396.09
Working Capital	-0.3	-0.22	-0.08	-0.02	-0.01
Book Value Per Share	-0.00	-0.00	-0.00	-0.00	-0.00
Tangible Book Value	-0.3	-0.22	-0.08	-0.02	-0.02
Tangible Book Value Per Share	-0.00	-0.00	-0.00	-0.00	-0.00

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.